Access to life-saving pharmaceuticals and medical treatments is a nagging problem for millions of Latin Americans. In several countries of the region, judicial actions for the protection of basic rights have proved to be instrumental for gaining access to such goods. Brazil and Colombia are, allegedly, the two Latin American countries with the largest number of right to health cases. Everaldo Lamprea suggests that dismantling right to health litigation in order to reduce public costs--as was recently proposed by the Colombian government-- would be a catastrophic event for many Colombians, trapped in a heavily privatized and deregulated health system where many life-saving pharmaceuticals and medical treatments are out of the reach of most pockets. Lamprea will suggest that a more reasonable governmental reaction should include an analysis of the role played in the current health-sector crisis by global actors such as International Financial Institutions and BigPharma companies
Sponsored by the Program on Human Rights and the Program on Global Justice.